Interventional Oncology Devices | Market Insights | US | 2022
Despite the short-term challenges posed by the COVID-19 pandemic, the US market for interventional oncology devices will grow modestly through 2030. This will be driven largely by the expanding treatable patient populations, an increasing shift towards higher-priced technologies, and growing physician acceptance of interventional oncology procedures. However, growth in this market will be hindered by mixed clinical data and a lack of reimbursement for newer technologies, which has led to a tempered adoption of interventional oncology devices.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across an 11-year period.
